Pharmacists in South Dakota - Medicare Status, Address, Contact

987 Pharmacists found. Showing 61 - 80

Alexandra Peters, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 790 22nd Ave S, Brookings, SD 57006 Phone: 605-692-7311

Theresa B Frederick, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2233 6th St, Brookings, SD 57006 Phone: 605-692-1858

Makenzie Aesoph Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2233 6th St, Brookings, SD 57006 Phone: 605-692-1858

Hailey Arlene Will, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2233 6th St, Brookings, SD 57006 Phone: 605-692-1858

Sarah Mcgill Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 400 22nd Ave, Brookings, SD 57006 Phone: 605-697-9544

Kaylee Ann Granum Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 910 22nd Ave S, Brookings, SD 57006 Phone: 605-692-8881

Jennifer Prussman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1440 N Campus Dr, Brookings, SD 57007 Phone: 605-688-5410

Corrina Hemmer Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1004 6th St, Brookings, SD 57006 Phone: 605-692-2088

Mr. Arne Albert Anderson Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 303 E 5th St, Canton, SD 57013 Phone: 605-987-2661    Fax: 605-987-2478

Dr. Robert Halverson, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 715 E 5th St, Canton, SD 57013 Phone: 605-987-4284    Fax: 605-987-4156

Bailey Schroeder, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 303 E 5th St, Canton, SD 57013 Phone: 605-987-2661

Mrs. Austin Rae Block, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 303 E 5th St, Canton, SD 57013 Phone: 605-987-2661    Fax: 605-987-2478

Cody D Carstensen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 512 Broadway, Centerville, SD 57014 Phone: 605-563-2243

Cassi Lynne Leiferman, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 S Byron Blvd, Chamberlain, SD 57325 Phone: 605-234-7110

Mr. James Loren Butler, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 201 N Main St, Chamberlain, SD 57325 Phone: 605-734-5871    Fax: 605-734-4245

Drew Ruhlman Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 201 N Main St, Chamberlain, SD 57325 Phone: 605-234-5871

Timothy John Travis, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 201 N Main St, Chamberlain, SD 57325 Phone: 605-234-5871

Nicholas Elgersma, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 201 N Main St, Chamberlain, SD 57325 Phone: 605-234-5871

Terry F Casey, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 201 N Main St, Chamberlain, SD 57325 Phone: 605-734-5871    Fax: 605-734-4245

James D Bregel, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 201 N Main St, Chamberlain, SD 57325 Phone: 605-734-5871

News Archive

Functional MRI can be used to assess tumor viability

Pancreatic ductal adenocarcinoma (the disease commonly referred to as pancreatic cancer) carries the worst prognosis of any cancer. As current treatments offer minimal benefit, entirely new approaches are needed. Given the success of local therapies, as opposed to intravenous systemic therapies, for liver diseases (such as hepatocellular carcinoma), it is thought that similar local therapies may benefit patients with pancreatic cancer. To develop such therapies, it would be useful to devise targets that are easy to obtain and can indicate the efficacy of these new therapies in models of pancreatic cancer.

Magellan Health Services reports net revenue of $728.1M for first-quarter ended March 31, 2010

Magellan Health Services, Inc. today reported net revenue of $728.1 million, net income of $25.5 million or $0.73 per diluted common share, and segment profit, representing income from continuing operations before stock compensation expense, depreciation and amortization, interest expense, interest income, gain on sale of assets, special charges or benefits, and income taxes, of $61.4 million for the quarter ended March 31, 2010.

Comprehensive genomic analysis of low-grade brain tumors sorts into three categories

Comprehensive genomic analysis of low-grade brain tumors sorts them into three categories, one of which has the molecular hallmarks and shortened survival of glioblastoma multiforme, the most lethal of brain tumors, researchers reported at the American Association for Cancer Research Annual Meeting 2014.

New approach to treating neonatal hypoxic ischemia improves outcomes in preclinical models

Hypothermia alone, the current standard of care, neuroprotects roughly 50 percent of newborns with moderate to severe hypoxic ischemia. Therefore, half of all affected newborns are left with developmental, cognitive and motor delays including cerebral palsy following injury.

Obama: 'Take time' on health reform, Democrats haggle on next steps

ABC News: "Summoning the message back that once mobilized his grass-roots campaign, the president spoke tonight in front of the same people - Organizing for America and DNC members - whose poll show some are feeling somewhat discouraged by the first year of the Obama administration. ... The president outlined in broad strokes what he'd like to see happen [on health reform]. 'What I'd like to do is have a meeting where I'm sitting with the Republicans, sitting with the Democrats.

Read more Medical News

› Verified 9 days ago

• 1
• 2
• 3
• 4(current)
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• »